Roche’s Setback: Giredestrant Fails in Key Breast Cancer Trial
Shares in Roche tumbled Monday, dropping more than 5%, as the Swiss pharmaceutical giant faced disappointment with…
Roche Stock Falls as Breast Cancer Drug Fails Trial Goals
In a significant setback, Roche’s shares suffered a steep drop exceeding 7% at one point on Monday…
Roche shares fall after breast cancer drug fails trial
Shares in Roche dropped more than 5% on March 9 after the Swiss pharmaceutical company announced that its…